Skip to content

Popelin Apotheken

Active
Private limited companyfounded 2024active for 2 yearsMarie Curiesquare 30, 1070 Anderlecht, Belgium15 active companies are registered at this addressKBO/BCE: BE 1004.967.609
Summary

The computed 12-month bankruptcy probability of Popelin Apotheken is 1.7% (moderate). The 2025 annual accounts show equity of €4.1m and a net result of -€191,825. Its solvency ranks better than 19% of 5,019 sector peers (NACE 47, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
Popelin ApothekenActiveChecked score 54/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730Wholesale of pharmaceutical and medical goods NACE 46460
6th largest employer in Anderlecht, Wholesale and retail trade sector79 sites
Size
€152.2mturnover 2025
Staff
361.8 FTE
Equity
€4.1m
Loss
-€191,825
Financial health
54 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
1.7%
Structure
Parent
Multipharma Group SC
Holdings
6
  • DeprinceDirector · permanent representative DEPRINCE Leo Albert Jeanne Martha Gustaaf
  • L&JDirector · permanent representative KUYPS Jan Constantia Leo
  • Geert REYNIERSDirector
Auditor: Deloitte Bedrijfsrevisoren2025 accounts 36 days early
Why 54raises riskFounded in 20241 change of registered office in 24 monthslowers riskSize: turnover €152.2m, 361.8 FTE, total assets €51.2mFigures for financial year 2025 (filed 25-06-2026)Show the evidence

Checked score

Score 2025
54 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 37% of its sector peers (NACE 47, large)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 33-1
equity 8.0% of total assets
Liquidity 37+29
short-term debt 48.8% · cash 9.0%
Profitability 33-28
return on assets -0.4%
Bankruptcy probability, 12 months
1.7% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (83 companies, NACE 47, large)
Last 24 months 02-2025: 1.9% 03-2025: 1.9%● unchanged vs 02-2025 04-2025: 4.0%▲ +2.1 percentage points vs 03-2025 05-2025: 4.4%▲ +0.4 percentage points vs 04-2025 06-2025: 4.6%▲ +0.2 percentage points vs 05-2025 07-2025: 5.0%▲ +0.4 percentage points vs 06-2025 08-2025: 5.2%▲ +0.2 percentage points vs 07-2025highest value 09-2025: 2.6%▼ -2.6 percentage points vs 08-2025 10-2025: 2.6%● unchanged vs 09-2025 11-2025: 2.6%● unchanged vs 10-2025 12-2025: 2.6%● unchanged vs 11-2025 01-2026: 2.7%▲ +0.1 percentage points vs 12-2025 02-2026: 2.6%▼ -0.1 percentage points vs 01-2026 03-2026: 2.7%▲ +0.1 percentage points vs 02-2026 04-2026: 3.1%▲ +0.4 percentage points vs 03-2026 05-2026: 3.7%▲ +0.6 percentage points vs 04-2026 06-2026: 3.9%▲ +0.2 percentage points vs 05-2026 07-2026: 4.0%▲ +0.1 percentage points vs 06-2026 08-2026: 3.5%▼ -0.5 percentage points vs 07-2026 09-2026: 3.5%● unchanged vs 08-2026 10-2026: 1.7%▼ -1.8 percentage points vs 09-2026lowest value
Credit of up to €220,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity tight (current ratio 1.07, compared with 0.62 in 2024, below the usual 1.5; short-term debt: 48.8% and cash: 9% of total assets), and 92% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, large): better than 14% on solvency, 69% on liquidity, 20% on profitability and 44% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Founded in 2024
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: turnover €152.2m, 361.8 FTE, total assets €51.2m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 25-06-2026)
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 5019 sector peers (2025).
NBB · sector comparison
Position among 5019 sector peers
Solvency
better than 19%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-06-2026, 36 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
36 days early
2024
12 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 12 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
28-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Resignations & appointmentsPower of attorney
  2. Annual accounts filedfinancial year 2025 · full…
  3. Permanent representative: Philippe Van CoppenolleGazette deed

Key points

  • Caution: From profit to loss in 2025after €2.5m in 2024 -€191,825 View
  • Caution: Among the weakest 8% on net resultsector median €39,953 · 5,018 companies -€191,825 View
  • Controlled by Multipharma Group SCthe company in turn controls 6 companies parent View

By topic

Financials

Financial year
2025
Turnover
€152.2m
Loss
-€191,825
Solvency
8.0%
Turnover▲ 2.9%
Net result
20242025
Go to Financials

Board & ownership

Board
3 members
Parent
Multipharma Group SC
Auditor
Deloitte Bedrijfsrevisoren
  • DeprinceDirector
  • L&JDirector
  • Geert REYNIERSDirector
Go to Board & ownership

Network & group

Subsidiaries
6
Connected companies
28
Mergers and asset contributions
1

6 subsidiaries

Go to Network & group

Timeline

Events
13
Since
2024
Next accounts
by 31-07-2027
  1. 12-08-2025Annual accounts filed
  2. 11-03-2025Resignations: Hilde DE WOLF, Steven HERMANS and…
  3. 06-03-2025Registered office · Name
Go to Timeline

Company details

Sites
79
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
19-01-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
20
Who signs
Two directors jointly
Annual meeting
Second Thursday of June at 14:00
Purpose
“Productie en distributie van geneesmiddelen, parafarmaceutische producten en hulpmiddelen…” (deed in Dutch)
Go to Articles of association

Key facts about Popelin Apotheken

What is the company number of Popelin Apotheken?
1004.967.609. In Belgium the VAT number is the company number with BE in front: BE 1004.967.609.
Where is Popelin Apotheken based?
The registered office is at Marie Curiesquare 30, 1070 Anderlecht.Company details
What does Popelin Apotheken do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Popelin Apotheken?
Private limited company (BV).
When was Popelin Apotheken founded?
On 19-01-2024.
Is Popelin Apotheken still active?
Yes, Popelin Apotheken is an active enterprise in the KBO register.
How many employees does Popelin Apotheken have?
On average 361.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Popelin Apotheken?
€152.2m in financial year 2025, according to the filed annual accounts.
Is Popelin Apotheken profitable?
In financial year 2025, Popelin Apotheken made a loss of €191,825.
Where can I find the annual accounts of Popelin Apotheken?
Popelin Apotheken filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Popelin Apotheken due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Popelin Apotheken

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure